Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Purpose. Injection of anti-VEGF antibody into the vitreous body is a well-established treatment for ischemic central retinal vein occlusion (CRVO) associated macular edema. Various treatment regimens regarding the timing, number, and frequency of injections have been proposed. Methods. We reviewed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Pikkel, Otzem Chassid, Yumna Busool, Ward Srour, Adi Sharabi-Nov, Itzchak Beiran
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2013/974670
Tags: Add Tag
No Tags, Be the first to tag this record!